Clicky

Mesoblast Limited(LWB) News

Date Title
Jul 28 Mesoblast Limited (MESO) Launches First Cell Therapy for Children
Jul 24 ASX Growth Stocks With High Insider Stakes
Jul 24 High Growth Tech Stocks To Watch In Australia July 2025
Jul 22 Mesoblast Limited (MESO) Is Up 40.59% in One Week: What You Should Know
Jul 21 [Latest] Global Cardiac Tissue Engineering Market Size/Share Worth USD 2,943.92 Million by 2034 at a 16.65% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Jul 18 Successful Commercial Launch of Ryoncil®
Jul 1 Mesoblast and FDA Align on Key Items for Revascor® Biologic License Application in Ischemic Heart Failure
Jun 29 Mesoblast (MESO) Gets 7 Years of Orphan-drug Exclusive Approval from US FDA for Ryoncil
Apr 17 Mesoblast Extends Payer Coverage For Ryoncil® to Over 100 Million US Lives
Mar 12 Mesoblast CEO to Deliver Featured Presentation at ISCT North America Virtual Town Hall
Mar 10 Mesoblast Limited (MESO): Among the Best Australian Stocks to Buy According to Billionaires
Mar 6 Mesoblast Added to S&P/ASX 200 INDEX
Mar 4 While Mesoblast (ASX:MSB) shareholders have made 667% in 1 year, increasing losses might now be front of mind as stock sheds 8.7% this week
Feb 13 Ryoncil® FDA Approval and Market Launch Highlighted at Tandem Transplantation Meetings
Feb 12 Domino's Pizza Enterprises And 2 Other ASX Stocks That Might Be Trading Below Fair Value
Jan 3 MESO Stock Surges 80% in a Month After FDA Approval of GVHD Drug
Jan 3 Exploring 3 High Growth Tech Stocks In Australia